Skip to content
BillRazor
Generic J3301 · Anti-inflammatory / Steroids

TRIAMCINOLONE ACET 200 MG/5 ML

TRIAMCINOLONE ACET 200 MG/5 ML, a generic anti-inflammatory steroid, has a NADAC acquisition cost of $3.99, though hospital charges typically range 5-20x higher than acquisition costs.

By Priya Iyengar , Senior Billing Analyst · ·
Data from CMS files published FY 2024 CMS IPPS. Refreshed weekly.
About the analyst

Priya Iyengar leads the billing code review team at BillRazor Research. She analyzes NCCI bundling edits, DRG coding, and regional rate variation. Expertise: NCCI bundling, DRG analysis, regional pricing.

NADAC acquisition cost data
CMS drug pricing benchmarks
Updated 2026-04-03
Drug acquisition cost — TRIAMCINOLONE ACET 200 MG/5 ML
NADAC cost$3.99 per unit
Hospital charges for this drug vary — typically 3–8x the acquisition cost. No observed hospital charge data is available for this specific drug.
$3.99
NADAC acquisition cost
INJECTABLE
Dosage form
INJECTION
Route

Triamcinolone acetonide is an anti-inflammatory steroid used to treat various inflammatory conditions including arthritis, allergies, and skin disorders. This generic formulation typically generates lower reimbursement rates compared to brand-name alternatives, with Medicare benchmark pricing varying significantly across different care settings.

Check your bill amount
Enter the charge for TRIAMCINOLONE ACET 200 MG/5 ML from your bill to compare against the NADAC acquisition cost.
$

No credit card required. Results in 60 seconds.

Research suggests 49–80% of hospital bills contain errors. Our system checks every line item against Medicare benchmarks.
Rates shown are from the 2026 Medicare Physician Fee Schedule and CMS IPPS. BillRazor compares your bill against these data sources. See how it works →

Related pricing data

Data source: National Average Drug Acquisition Cost (NADAC) survey, published by CMS. HCPCS drug pricing codes from Medicare Part B Drug Average Sales Price file.

What NADAC means: The average price pharmacies pay to acquire this drug from wholesalers. Hospital charges for the same drug are typically higher due to facility fees, compounding, and administration costs.

Limitations: NADAC reflects pharmacy acquisition cost, not patient out-of-pocket cost. Insurance copays, formulary tiers, and manufacturer rebates affect what patients actually pay.

Upload your bill — free instant analysis